JP2009514966A5 - - Google Patents

Download PDF

Info

Publication number
JP2009514966A5
JP2009514966A5 JP2008540139A JP2008540139A JP2009514966A5 JP 2009514966 A5 JP2009514966 A5 JP 2009514966A5 JP 2008540139 A JP2008540139 A JP 2008540139A JP 2008540139 A JP2008540139 A JP 2008540139A JP 2009514966 A5 JP2009514966 A5 JP 2009514966A5
Authority
JP
Japan
Prior art keywords
magnesium
pharmaceutical composition
aliphatic amine
amine polymer
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008540139A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009514966A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/043402 external-priority patent/WO2007056405A2/en
Publication of JP2009514966A publication Critical patent/JP2009514966A/ja
Publication of JP2009514966A5 publication Critical patent/JP2009514966A5/ja
Withdrawn legal-status Critical Current

Links

JP2008540139A 2005-11-08 2006-11-07 高リン血症のためのマグネシウム含有重合体 Withdrawn JP2009514966A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73459305P 2005-11-08 2005-11-08
PCT/US2006/043402 WO2007056405A2 (en) 2005-11-08 2006-11-07 Magnesium-containing polymers for the treatment of hyperphosphatemia

Publications (2)

Publication Number Publication Date
JP2009514966A JP2009514966A (ja) 2009-04-09
JP2009514966A5 true JP2009514966A5 (enExample) 2009-12-24

Family

ID=37888157

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008540139A Withdrawn JP2009514966A (ja) 2005-11-08 2006-11-07 高リン血症のためのマグネシウム含有重合体

Country Status (8)

Country Link
US (1) US20090162314A1 (enExample)
EP (1) EP1945196A2 (enExample)
JP (1) JP2009514966A (enExample)
CN (1) CN101304739A (enExample)
AR (1) AR060690A1 (enExample)
BR (1) BRPI0618352A2 (enExample)
CA (1) CA2626734A1 (enExample)
WO (1) WO2007056405A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2756942C (en) * 2009-04-10 2019-01-08 Cypress Pharmaceuticals, Inc. Phosphate-binding magnesium salts and uses thereof
US8247000B2 (en) 2009-04-10 2012-08-21 Cypress Pharmaceutical, Inc. Phosphate-binding magnesium salts and uses thereof
CN103159880B (zh) * 2011-12-14 2016-06-22 上海亿法医药科技有限公司 碳酸司维拉姆的制备方法
US9394318B2 (en) 2012-11-30 2016-07-19 Cypress Pharmaceuticals, Inc. Crystal polymorph of magnesium glycinate dihydrate and process for its preparation
DK3287133T3 (da) 2013-06-05 2019-07-01 Tricida Inc Proton-bindende polymerer til oral indgivelse
KR102625115B1 (ko) * 2014-12-10 2024-01-12 트리시다, 인크. 경구 투여용 양성자-결합 폴리머
US9649335B1 (en) * 2016-03-30 2017-05-16 Baylor University Intravenous administration of an oxygen-enabled fluid
KR102655774B1 (ko) 2016-05-06 2024-04-05 트리시다, 인크. 산-염기 장애의 치료를 위한 조성물 및 방법
JP6792640B2 (ja) 2016-12-28 2020-11-25 富士フイルム株式会社 窒素原子含有ポリマー又はその塩の乳化液、その製造方法、及び粒子の製造方法
TW201922249A (zh) * 2017-09-29 2019-06-16 日商第一三共股份有限公司 二羧酸化合物與磷吸附劑之組合
CN111225674A (zh) * 2017-10-16 2020-06-02 富士胶片株式会社 高磷血症治疗剂
IL319146A (en) 2017-11-03 2025-04-01 Tricida Inc Compositions for and method of treating acid-base disorders

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2456428A (en) * 1944-10-11 1948-12-14 Shell Dev Polyallyl amine and related polymeric amines
US3104205A (en) * 1959-12-17 1963-09-17 Warner Lambert Pharmaceutical Deodorant composition comprising the copper complex of the copolymer of allylamine and methacrylic acid
US3308020A (en) * 1961-09-22 1967-03-07 Merck & Co Inc Compositions and method for binding bile acids in vivo including hypocholesteremics
US3332841A (en) * 1961-10-04 1967-07-25 Lilly Co Eli Method of treating hyperacidity
US3624209A (en) * 1966-12-28 1971-11-30 Bristol Myers Co Composition for treatment of gastro-intestinal disorders
US3980770A (en) * 1971-06-04 1976-09-14 Pharmacia Aktiebolag Polymerization products containing amino groups useful in serum cholesterol level control
US4205064A (en) * 1973-06-11 1980-05-27 Merck & Co., Inc. Bile acid sequestering composition containing poly[{alkyl-(3-ammoniopropyl)imino}-trimethylenedihalides]
US4181718A (en) * 1975-12-29 1980-01-01 Mason Norbert S Polyanion-stabilized aluminum hydrogels
US4071478A (en) * 1976-06-07 1978-01-31 Merck & Co., Inc. Controlled partially cross-linked 3,3-ionenes
US4143130A (en) * 1977-08-29 1979-03-06 Warren-Teed Laboratories, Inc. Method for treating kidney stones
US4247393A (en) * 1979-01-11 1981-01-27 Wallace Richard A Hemodialysis assist device
US4344993A (en) * 1980-09-02 1982-08-17 The Dow Chemical Company Perfluorocarbon-polymeric coatings having low critical surface tensions
US4504640A (en) * 1982-05-19 1985-03-12 Nitto Boseki Co., Ltd. Process for producing monoallylamine polymer
DE3241113A1 (de) * 1982-11-06 1984-05-10 Bayer Ag, 5090 Leverkusen Vakzinen mit zuschlagstoffen
JPS6090243A (ja) * 1983-10-25 1985-05-21 Nitto Boseki Co Ltd 小球状モノアリルアミン橋かけ重合体の製造方法
CA1220897A (en) * 1984-01-11 1987-04-21 Kiyoshi Shimizu Process for producing polymers of monoallylamine
DE3402878A1 (de) * 1984-01-27 1985-08-01 Algina AG, Zug Arzneimittel und die verwendung schwerloeslicher calcium- und/oder magnesiumverbindungen als arzneimittel
US4631305A (en) * 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
DE3541511A1 (de) * 1985-11-19 1987-05-21 Grace W R Ab Promoter fuer die papierleimung, verfahren zu dessen herstellung und dessen verwendung
US6274713B1 (en) * 1989-04-07 2001-08-14 Salutar, Inc. Polychelants
US5236701A (en) * 1989-07-19 1993-08-17 Lowchol Scientific Inc. Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol
US5053423A (en) * 1990-03-22 1991-10-01 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
US5055197A (en) * 1991-04-05 1991-10-08 Rohm And Haas Company Process for removing residual monomers and oligemers from amine-containing polymers
US5108767A (en) * 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
EP0580079B1 (de) * 1992-07-22 1996-12-11 Hoechst Aktiengesellschaft Vernetzte, stickstoffhaltige Vinylcopolymere, Verfahren zu ihrer Herstellung sowie die Verwendung dieser Verbindungen
ES2110543T3 (es) * 1992-07-22 1998-02-16 Hoechst Ag Derivados de poli(vinil-aminas) que tienen centros hidrofilos, procedimiento para su preparacion asi como la utilizacion de los compuestos como medicamentos, vehiculos de sustancias activas e ingredientes auxiliares para alimentos.
US5302531A (en) * 1992-10-22 1994-04-12 Miles Inc. Composition for the semiquantitative determination of specific gravity of a test sample
US5487888A (en) * 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
US5929184A (en) * 1993-06-02 1999-07-27 Geltex Pharmaceuticals, Inc. Hydrophilic nonamine-containing and amine-containing copolymers and their use as bile acid sequestrants
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5414068A (en) * 1994-01-24 1995-05-09 Rohm And Haas Company Crosslinked anion exchange particles and method for producing the particles
EP0922461A4 (en) * 1996-07-19 2002-07-17 Nikken Chemicals Co Ltd MEDICINE AGAINST HYPERPHOSPHATANEMIA
US5753706A (en) * 1996-12-16 1998-05-19 Hsu; Chen Hsing Methods for treating renal failure
GB9720061D0 (en) * 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
US6566407B2 (en) * 1997-11-05 2003-05-20 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
EP0949290B1 (en) * 1998-04-09 2006-12-27 Nippon Shokubai Co., Ltd. Crosslinked polymer particle and its production process and use
DE19835467A1 (de) * 1998-08-06 2000-02-17 Elenac Gmbh Feststoffreaktor mit antistatischer Beschichtung zur Durchführung von Reaktionen in der Gasphase
DE19917705C1 (de) * 1999-04-20 2000-12-28 Vitasyn Gmbh Mittel zur Therapie von Hyperphosphatämie
US6733780B1 (en) * 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
AU2001289699B2 (en) * 2000-07-28 2006-06-01 Cheplapharm Arzneimittel Gmbh New pharmaceutical composition
WO2002085380A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for treating gout and reducing serum uric acid
JP4499363B2 (ja) * 2001-04-18 2010-07-07 ジェンザイム コーポレーション 血清グルコースの減少方法
WO2002085379A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for improving vascular access in patients with vascular shunts
BR0209133A (pt) * 2001-04-18 2004-06-15 Genzyme Corp Método para tratar gota e para reduzir os nìveis de ácido úrico n0 sangue
JP4303595B2 (ja) * 2001-12-21 2009-07-29 透 小池 アニオン性置換基を有する物質を捕捉可能な亜鉛錯体
US20040115265A1 (en) * 2002-12-11 2004-06-17 Loutfy Benkerrour Multilayered tablet containing pravastatin and aspirin and method
WO2004085448A2 (en) * 2003-03-19 2004-10-07 Genzyme Corporation Unsaturated phosphinyl-phosphonate phosphate transport inhibitors
JP2007517047A (ja) * 2003-12-31 2007-06-28 ジェンザイム・コーポレーション 腸溶コーティングされた脂肪族アミンポリマーの胆汁酸捕捉因子
US7019085B2 (en) * 2004-08-30 2006-03-28 Albright Robert L Phosphate selective resin and related methods
US7985418B2 (en) * 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders

Similar Documents

Publication Publication Date Title
JP2009514966A5 (enExample)
JP2013523975A5 (enExample)
JP2018502956A5 (enExample)
JP2010530897A5 (enExample)
JP2008505157A5 (enExample)
JP2013057058A5 (ja) ブロック共重合体の塗膜
JP2016508505A5 (enExample)
JP2006182786A5 (enExample)
JP2009535307A5 (enExample)
JP2013185119A5 (enExample)
JP2009502743A5 (enExample)
JP2016514192A5 (enExample)
JP2009543802A5 (enExample)
JP2010535870A5 (enExample)
JP2013542992A5 (enExample)
JP2011506706A5 (enExample)
JP2010521516A5 (enExample)
JP2011506704A5 (enExample)
JP2012531508A5 (enExample)
JP2010215619A5 (enExample)
JP2014097948A5 (enExample)
JP2010534246A5 (enExample)
JP2012520271A5 (enExample)
JP2013515037A5 (enExample)
JP2013513607A5 (enExample)